目次

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS
3.1 DISPOSABLE ENDOSCOPES MARKET OVERVIEW
3.2 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER
3.3 GEOGRAPHIC SNAPSHOT OF DISPOSABLE ENDOSCOPES MARKET (2024)
3.4 GEOGRAPHIC MIX: DISPOSABLE ENDOSCOPES MARKET, 2025-2030 (USD MILLION)
3.5 DISPOSABLE ENDOSCOPES MARKET: DEVELOPING VS. DEVELOPED MARKETS

4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Growing demand for infection control and regulatory push
4.2.1.2 Rising burden of chronic diseases
4.2.2 RESTRAINTS
4.2.2.1 Environmental impact and sustainability concerns
4.2.3 OPPORTUNITIES
4.2.3.1 Rapidly developing healthcare sector in emerging economies
4.2.4 CHALLENGES
4.2.4.1 High upfront expenditure per procedure
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS IN DISPOSABLE ENDOSCOPES MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNTIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNTIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 BARGAINING POWER OF SUPPLIERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL ENDOSCOPY EQUIPMENT IDUSTRY
5.2.4 TRENDS IN GLOBAL FLEXIBLE ENDOSCOPES INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY KEY PLAYER (2022-2024)
5.6.2 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY TYPE (2022-2024)
5.6.3 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY REGION (2022-2024)
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 9018)
5.7.2 EXPORT DATA (HS CODE 9018)
5.8 KEY CONFERENCES & EVENTS, 2025-2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 CASE STUDY 1: ICU BRONCHOSCOPY PERFORMANCE AND ADOPTION
5.11.2 CASE STUDY 2: ERCP INFECTION CONTROL CONVERSION PATHWAY
5.11.3 CASE STUDY 3: OPTIMIZING TRANSBRONCHIAL CRYOBIOPSY IN INTERSTITIAL LUNG DISEASE USING AMBU ASCOPE 5 BRONCHO HD
5.12 IMPACT OF 2025 US TARIFFS ON DISPOSABLE ENDOSCOPES MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON COUNTRIES/REGIONS
5.12.4.1 North America
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.5 END-USE INDUSTRY IMPACT

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 CMOS & CCD IMAGING SENSORS
6.1.2 FIBER-OPTIC ILLUMINATION SYSTEMS
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 AI-ASSISTED IMAGE PROCESSING AND VISUALIZATION
6.3 TECHNOLOGY/PRODUCT ROADMAP
6.3.1 SHORT TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.3.2 MID TERM (2027-2030) | EXPANSION & STANDARDIZATION
6.3.3 LONG TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.4 PATENT ANALYSIS
6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.5 FUTURE APPLICATIONS
6.5.1 AI-ENABLED VISUALIZATION AND DIAGNOSTIC SUPPORT
6.5.2 BIODEGRADABLE & ECO-FRIENDLY ENDOSCOPES
6.5.3 SMART ENDOSCOPES WITH EMBEDDED SENSORS
6.6 IMPACT OF AI/GEN AI ON DISPOSABLE ENDOSCOPES MARKET
6.6.1 TOP USE CASES & MARKET POTENTIAL
6.7 BEST PRACTICES IN DISPOSABLE ENDOSCOPES PROCESSING
6.7.1 CASE STUDIES OF AI IMPLEMENTATION IN DISPOSABLE ENDOSCOPES MARKET
6.7.2 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS
6.7.3 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN DISPOSABLE ENDOSCOPES MARKET

7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF DISPOSABLE ENDOSCOPES
7.2.1.1 Carbon impact reduction
7.2.1.2 Eco-applications
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 DISPOSABLE ENDOSCOPES MARKET, BY TYPE
9.1 INTRODUCTION
9.2 UROLOGY ENDOSCOPES
9.2.1 UROLOGY ENDOSCOPES SEGMENT TO HOLD MAJOR SHARE OF MARKET
9.3 BRONCHOSCOPES
9.3.1 RISING PREVALENCE OF LUNG CANCER TO BOOST SEGMENTAL GROWTH
9.4 CYSTOSCOPES
9.4.1 GROWING BURDEN OF BLADDER CANCER TO AID SEGMENTAL GROWTH
9.5 GI ENDOSCOPES
9.5.1 STRINGENT REGULATORY RECOMMENDATIONS FROM US FDA TO ACCELERATE SHIFT TOWARD SINGLE-USE GI ENDOSCOPES
9.6 LARYNGOSCOPES
9.6.1 RISING INFECTION CONTROL AND INCREASING LARYNGEAL DISORDER BURDEN TO DRIVE SEGMENTAL GROWTH
9.7 ARTHROSCOPES
9.7.1 RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH
9.8 OTHER DISPOSABLE ENDOSCOPES

10 DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE
10.1 INTRODUCTION
10.2 SURGICAL USAGE
10.2.1 RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH
10.3 DIAGNOSTIC USAGE
10.3.1 RISING PREFERENCE FOR SAFE AND EFFICIENT DIAGNOSTIC PROCEDURES TO DRIVE ADOPTION OF DISPOSABLE ENDOSCOPES

11 DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION
11.1 INTRODUCTION
11.2 UROLOGY
11.2.1 RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO AID MARKET GROWTH
11.3 BRONCHOSCOPY
11.3.1 RISING INFECTION CONTROL NEEDS TO DRIVE GROWTH OF BRONCHOSCOPY SEGMENT
11.4 GASTROENTEROLOGY
11.4.1 TECHNOLOGICAL ADVANCEMENTS AND GROWING PROCEDURAL VOLUMES IN HOSPITAL ENDOSCOPY UNITS TO FUEL DEMAND
11.5 ENT
11.5.1 ABILITY OF DISPOSABLE ENT ENDOSCOPES TO REDUCE CROSS-CONTAMINATION RISKS TO DRIVE DEMAND
11.6 OTHER APPLICATIONS

12 DISPOSABLE ENDOSCOPES MARKET, BY END USER
12.1 INTRODUCTION
12.2 HOSPITALS
12.2.1 HOSPITALS TO DOMINATE DISPOSABLE ENDOSCOPES MARKET DURING FORECAST PERIOD
12.3 AMBULATORY SURGERY CENTERS
12.3.1 GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND TECHNOLOGICAL ADVANCEMENTS TO ACCELERATE GROWTH
12.4 CLINICS
12.4.1 RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND MINOR PROCEDURES TO DRIVE SEGMENTAL GROWTH
12.5 OTHER END USERS

13 DISPOSABLE ENDOSCOPES MARKET, BY REGION
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
13.2.2 US
13.2.2.1 US to dominate North American disposable endoscopes market during forecast period
13.2.3 CANADA
13.2.3.1 Stringent infection control standards and rising chronic disease burden to adoption of disposable endoscopes
13.3 EUROPE
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
13.3.2 GERMANY
13.3.2.1 Germany to dominate European disposable endoscopes market
13.3.3 UK
13.3.3.1 Growing aging population and infection control focus to boost market
13.3.4 FRANCE
13.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
13.3.5 ITALY
13.3.5.1 Increasing aging population and prevalence of chronic diseases to boost adoption of disposable endoscopes
13.3.6 SPAIN
13.3.6.1 Rising aging population to drive market growth
13.3.7 REST OF EUROPE
13.4 ASIA PACIFIC
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.2 CHINA
13.4.2.1 China to account for largest share of APAC region in disposable endoscopes market
13.4.3 JAPAN
13.4.3.1 Increasing chronic diseases and geriatric population to drive Japan’s growth in market
13.4.4 INDIA
13.4.4.1 Rising disease burden and aging population to position India as key growth hub in Asia Pacific
13.4.5 AUSTRALIA
13.4.5.1 Rising cancer burden and expanding screening programs to support disposable endoscopes adoption in Australia
13.4.6 SOUTH KOREA
13.4.6.1 Robust cancer screening programs to drive strong adoption of disposable endoscopes
13.4.7 REST OF ASIA PACIFIC
13.5 LATIN AMERICA
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.2 BRAZIL
13.5.2.1 Brazil to account for largest share of LATAM market in 2024
13.5.3 MEXICO
13.5.3.1 Expanding healthcare infrastructure to strengthen Mexico’s position in global market
13.5.4 REST OF LATIN AMERICA
13.6 MIDDLE EAST & AFRICA
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
13.6.2 GCC COUNTRIES
13.6.2.1 Increasing healthcare investments and hospital expansions to drive market growth
13.6.3 REST OF MIDDLE EAST & AFRICA

14 COMPETITIVE LANDSCAPE
14.1 INTRODUCTION
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET
14.3 REVENUE ANALYSIS, 2020-2024
14.4 MARKET SHARE ANALYSIS, 2024
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
14.5.1 STARS
14.5.2 EMERGING LEADERS
14.5.3 PERVASIVE PLAYERS
14.5.4 PARTICIPANTS
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
14.5.5.1 Company footprint
14.5.5.2 Region footprint
14.5.5.3 Type footprint
14.5.5.4 Application footprint
14.5.5.5 End-user footprint
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
14.6.1 PROGRESSIVE COMPANIES
14.6.2 RESPONSIVE COMPANIES
14.6.3 DYNAMIC COMPANIES
14.6.4 STARTING BLOCKS
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
14.6.5.1 Detailed list of key startups/SMEs
14.6.5.2 Competitive benchmarking of key startups/SMEs
14.7 COMPANY VALUATION & FINANCIAL METRICS
14.7.1 FINANCIAL METRICS
14.7.2 COMPANY VALUATION
14.8 BRAND/PRODUCT COMPARISON
14.9 COMPETITIVE SCENARIO
14.9.1 PRODUCT LAUNCHES & APPROVALS
14.9.2 DEALS
14.9.3 EXPANSIONS

15 COMPANY PROFILES
15.1 KEY PLAYERS
15.1.1 AMBU A/S
15.1.1.1 Business overview
15.1.1.2 Products offered
15.1.1.3 Recent developments
15.1.1.3.1 Product launches & approvals
15.1.1.3.2 Expansions
15.1.1.4 MnM view
15.1.1.4.1 Right to win
15.1.1.4.2 Strategic choices
15.1.1.4.3 Weaknesses & competitive threats
15.1.2 BOSTON SCIENTIFIC CORPORATION
15.1.2.1 Business overview
15.1.2.2 Products offered
15.1.2.3 Recent developments
15.1.2.3.1 Product approvals
15.1.2.3.2 Deals
15.1.2.4 MnM view
15.1.2.4.1 Right to win
15.1.2.4.2 Strategic choices
15.1.2.4.3 Weaknesses & competitive threats
15.1.3 OLYMPUS CORPORATION
15.1.3.1 Business overview
15.1.3.2 Products offered
15.1.3.3 Recent developments
15.1.3.3.1 Product approvals
15.1.3.3.2 Deals
15.1.3.4 MnM view
15.1.3.4.1 Right to win
15.1.3.4.2 Strategic choices
15.1.3.4.3 Weaknesses & competitive threats
15.1.4 HOYA CORPORATION
15.1.4.1 Business overview
15.1.4.2 Products offered
15.1.4.3 Recent developments
15.1.4.3.1 Deals
15.1.4.4 MnM view
15.1.4.4.1 Right to win
15.1.4.4.2 Strategic choices
15.1.4.4.3 Weaknesses & competitive threats
15.1.5 VERATHON INC.
15.1.5.1 Business overview
15.1.5.2 Products offered
15.1.5.3 Recent developments
15.1.5.3.1 Product launches
15.1.5.4 MnM view
15.1.5.4.1 Right to win
15.1.5.4.2 Strategic choices
15.1.5.4.3 Weaknesses & competitive threats
15.1.6 KARL STORZ SE & CO. KG
15.1.6.1 Business overview
15.1.6.2 Products offered
15.1.6.3 Recent developments
15.1.6.3.1 Product launches
15.1.6.3.2 Deals
15.1.7 HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.
15.1.7.1 Business overview
15.1.7.2 Products offered
15.1.7.3 Recent developments
15.1.7.3.1 Deals
15.1.8 INNOVEX MEDICAL CO., LTD.
15.1.8.1 Business overview
15.1.8.2 Products offered
15.1.9 SCIVITA MEDICAL
15.1.9.1 Business overview
15.1.9.2 Products offered
15.1.10 GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD.
15.1.10.1 Business overview
15.1.10.2 Products offered
15.2 OTHER PLAYERS
15.2.1 THE COOPER COMPANIES, INC.
15.2.2 ZHUHAI PUSEN MEDICAL TECHNOLOGY CO., LTD.
15.2.3 UROVIU CORPORATION
15.2.4 OTU MEDICAL
15.2.5 GI VIEW LTD.
15.2.6 TSC LIFE
15.2.7 RICHARD WOLF GMBH
15.2.8 DAICHUAN MEDICA
15.2.9 NEOSCOPE INC.
15.2.10 INTEGRATED ENDOSCOPY
15.2.11 HUGER MEDICAL INSTRUMENT CO., LTD.
15.2.12 XENOCOR
15.2.13 MACROLUX MEDICAL TECHNOLOGY CO., LTD.
15.2.14 SHENZHEN HUGEMED MEDICAL TECHNICAL DEVELOPMENT CO., LTD.
15.2.15 ZHEJIANG GEYI MEDICAL DEVICES CO., LTD.

16 RESEARCH METHODOLOGY
16.1 RESEARCH DATA
16.1.1 SECONDARY DATA
16.1.1.1 Key data from secondary sources
16.1.2 PRIMARY DATA
16.1.2.1 Key data from primary sources
16.1.2.2 Key industry insights
16.2 MARKET SIZE ESTIMATION
16.3 MARKET BREAKDOWN & DATA TRIANGULATION
16.4 MARKET RANKING ANALYSIS
16.5 STUDY ASSUMPTIONS
16.6 RESEARCH LIMITATIONS
16.6.1 METHODOLOGY-RELATED LIMITATIONS
16.6.2 SCOPE-RELATED LIMITATIONS
16.7 RISK ASSESSMENT

17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS